Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
about
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationStatin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?National surveillance definitions for hypertension prevalence and control among adultsAtrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment ParallelsSecular Trends in Prescription Patterns of Single-Pill Combinations of an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Plus a Thiazide Diuretic for Hypertensive Patients in TaiwanHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2012 update: a report from the American Heart AssociationComparing angiotensin II receptor blockers on benefits beyond blood pressurePrevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009.Optimizing blood pressure control in patients with chronic kidney disease.Treatment of hypertension in the elderly: data from an international cohort of hypertensives treated by cardiologists.Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.Aliskiren and valsartan combination therapy for the management of hypertension.Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertensionArterial stiffness and hypertension: chicken or egg?Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study)Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease statusAltered blood pressure progression in the community and its relation to clinical eventsReducing Adverse Self-Medication Behaviors in Older Adults with Hypertension: Results of an e-health Clinical Efficacy Trial.Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial).Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertension.Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans.Management of blood pressure in patients with type 2 diabetes mellitus: a nationwide survey in korean.The counseling African Americans to Control Hypertension (CAATCH) Trial: baseline demographic, clinical, psychosocial, and behavioral characteristics.Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.Prevalence and control of hypertension in iraqi diabetic patients: a prospective cohort study.Counseling African Americans to Control Hypertension: cluster-randomized clinical trial main effectsIncidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort studyRelationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans.Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008.Effect of psoriasis severity on hypertension control: a population-based study in the United KingdomOlmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular PharmacoloSeated cuff blood pressure-lowering efficacy of an olmesartan medoxomil-based treatment regimen in patients with type 2 diabetes mellitus.Multimorbidity and blood pressure control in 37 651 hypertensive patients from Danish general practice.Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition StudyControlled Blood Pressure in Iranian Patients: A Multi-Center Report.Ethnic disparities in blood pressure management in patients with hypertension after the introduction of pay for performance.
P2860
Q22306356-FC9D51C5-0DBC-4404-AE07-F5D0A85B29E5Q24602803-0297D18B-3738-4465-91E3-717B8C10BE2EQ26997838-DC4A595E-018C-4CCB-A26D-6DBB646B240EQ28067128-5CFDC8B4-32EF-4197-9529-382610B1D061Q28468718-5C6F501A-63AB-4AC0-A31D-2D1F1D963492Q29547236-0D3FD950-2C1F-4D12-BF7E-5391EDF09F40Q29547909-8D1CD511-89C3-4186-91BA-EEA2FEAF49D1Q30360678-25188166-92DD-4378-BC1E-1E3B928A74ECQ31115110-CF197AD9-9E71-4BB3-9FF9-DA419A90E183Q33979430-95BA419B-A32D-41DA-8B6C-2E823D2B9A9BQ34132711-1DEA852C-B7B8-4DD1-BF29-F53D2BF221AFQ34134884-A641E949-28EC-4869-AEC0-9274A639A506Q34139070-97393805-C667-4474-AA88-7344F13751B8Q34224601-1BF7230E-DEB9-401D-B138-77A4446471A5Q34239668-F7000A4F-80AB-4CDD-BDA6-FB7EE0740132Q34288162-C1297848-81D5-4230-964E-091F5DFF8981Q34402022-8026C716-DD4E-4963-90C3-8F461D0D63C9Q34487808-24476DA0-F769-4855-8810-E41DAED66C81Q34504959-155261C7-43FC-4997-8746-96A794829CF7Q34975871-1E6FB22C-7F51-4F8F-BC71-4865F0E4E9F0Q35167022-79D229B8-1957-455A-B0D7-8DC981331C67Q35210553-D2BC0FC6-0549-4552-BE56-115CA25496CFQ35228179-FA45A0E8-005F-4D3F-B876-0CE4149578C6Q35228187-6CA3C0AD-0F86-419C-A2F9-CDD96FCFC906Q35231988-2E94D28D-9DC6-43D0-80C8-5860734540A3Q35639129-FFA781FE-5FF3-4ACD-AA0D-EE76676EF313Q35763418-A048BCBA-01FB-4D5F-BE34-4F5241190125Q35996621-01A98A00-A987-4BC9-89C7-CE1AED622DBDQ36046007-F3292FC2-EC22-479E-BE36-324EDD5F61BAQ36201429-641A329B-5FA2-47F8-9611-3B68111196DFQ36328475-898612CF-8D02-4237-9C82-BADBAD5BEBF2Q36378746-2CE5195D-CEDD-4B3E-9BE7-46A9E6D8A5DFQ36506489-919765F2-CB1B-461B-9E16-CCA641FC5CF5Q36541873-797245E3-B654-4CBB-A62B-0A47FA51C12AQ36613362-1AD12D97-FE38-4380-ABED-9446228AA754Q36648999-DE557E44-4D26-4617-B2C4-A33737CC31C3Q36701801-010A686F-C74F-4F42-81F4-B9D1C5BC3318Q36838706-373D70E7-BCF6-4E0C-958C-AE32F325ED1FQ36918526-4D22E99D-A00D-4197-AED4-4765364DCB19Q36971609-A0B17A1B-2FF4-40C2-B30A-CDD1E74158B5
P2860
Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@en
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@nl
type
label
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@en
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@nl
prefLabel
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@en
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@nl
P2093
P1476
Inadequate control of hyperten ...... se comorbidities in 2003-2004.
@en
P2093
Gilbert L'Italien
Nathan D Wong
Roland Chen
Stanley S Franklin
Sue Ellen J Kline
Victor A Lopez
P304
P356
10.1001/ARCHINTE.167.22.2431
P407
P577
2007-12-01T00:00:00Z